Trials / Conditions / CLL Progression
CLL Progression
3 registered clinical trials studyying CLL Progression — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL NCT07342478 | Newave Pharmaceutical Inc | Phase 3 |
| Unknown | Prognostic Role of Platelet _lymphocyte and Neutrophil _monocyte in CLL NCT04811950 | Assiut University | — |
| Terminated | Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy NCT04149821 | Weill Medical College of Cornell University | Phase 2 |